BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 29760712)

  • 1. The Function of MicroRNAs in B-Cell Development, Lymphoma, and Their Potential in Clinical Practice.
    Zheng B; Xi Z; Liu R; Yin W; Sui Z; Ren B; Miller H; Gong Q; Liu C
    Front Immunol; 2018; 9():936. PubMed ID: 29760712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
    Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
    Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in B cell development and malignancy.
    Fernando TR; Rodriguez-Malave NI; Rao DS
    J Hematol Oncol; 2012 Mar; 5():7. PubMed ID: 22401860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA control of B cell tolerance, autoimmunity and cancer.
    Xiao C; Nemazee D; Gonzalez-Martin A
    Semin Cancer Biol; 2020 Aug; 64():102-107. PubMed ID: 32522353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in Normal and Malignant Hematopoiesis.
    Kotaki R; Koyama-Nasu R; Yamakawa N; Kotani A
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28696359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities of microRNAs in lymphomas.
    De Tullio G; De Fazio V; Sgherza N; Minoia C; Serratì S; Merchionne F; Loseto G; Iacobazzi A; Rana A; Petrillo P; Silvestris N; Iacopino P; Guarini A
    Molecules; 2014 Sep; 19(9):14723-81. PubMed ID: 25232701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in lymphoma, from diagnosis to targeted therapy.
    Jardin F; Figeac M
    Curr Opin Oncol; 2013 Sep; 25(5):480-6. PubMed ID: 23852382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for analyzing microRNA expression and function during hematopoietic lineage differentiation.
    Min H; Chen CZ
    Methods Mol Biol; 2006; 342():209-27. PubMed ID: 16957377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of B-cell development and function by microRNAs.
    de Yébenes VG; Bartolomé-Izquierdo N; Ramiro AR
    Immunol Rev; 2013 May; 253(1):25-39. PubMed ID: 23550636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs modulate hematopoietic lineage differentiation.
    Chen CZ; Li L; Lodish HF; Bartel DP
    Science; 2004 Jan; 303(5654):83-6. PubMed ID: 14657504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA in immunity and autoimmunity.
    Zhu S; Pan W; Qian Y
    J Mol Med (Berl); 2013 Sep; 91(9):1039-50. PubMed ID: 23636510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.
    Malpeli G; Barbi S; Zupo S; Tosadori G; Scardoni G; Bertolaso A; Sartoris S; Ugel S; Vicentini C; Fassan M; Adamo A; Krampera M; Scupoli MT; Croce CM; Scarpa A
    Oncotarget; 2017 Feb; 8(7):11809-11826. PubMed ID: 28107180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory network of microRNAs confers lineage commitment during early developmental trajectories of B and T lymphocytes.
    Nikhat S; Yadavalli AD; Prusty A; Narayan PK; Palakodeti D; Murre C; Pongubala JMR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34750254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA regulation of B cell receptor signaling.
    Borbet TC; Hines MJ; Koralov SB
    Immunol Rev; 2021 Nov; 304(1):111-125. PubMed ID: 34523719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential.
    Kersy O; Salmon-Divon M; Shpilberg O; Hershkovitz-Rokah O
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis.
    Suttamanatwong S
    Connect Tissue Res; 2017 Jan; 58(1):90-102. PubMed ID: 26963177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of microRNAs in immune cell development and differentiation.
    Liang TJ; Qin CY
    APMIS; 2009 Sep; 117(9):635-43. PubMed ID: 19703123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
    Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
    Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.